From Financial Modeling Prep: 2025-04-10 13:00:00

Neogen Corporation’s Chief Accounting Officer, John Patrick Moylan, displayed confidence in the company by purchasing 10,000 shares of NEOG stock. However, NEOG reported third-quarter earnings of $0.10 per share, falling short of the Zacks Consensus Estimate of $0.13.

The company, listed on the NASDAQ as NEOG, specializes in food and animal safety products. Despite the insider purchase, NEOG’s stock faced challenges with declining earnings. Competing with Bio-Rad Laboratories and Thermo Fisher Scientific, NEOG’s stock performance has raised investor concerns.

With a price-to-sales ratio of 1.33 and an enterprise value to sales ratio of 1.19, NEOG’s valuation relative to its sales is apparent. The company maintains a strong liquidity position with a current ratio of 3.91, providing a buffer against short-term financial obligations. However, the enterprise value to operating cash flow ratio is high at 57.70, indicating a high valuation compared to cash flow.



Read more at Financial Modeling Prep:: Neogen Corporation’s Insider Purchase and Financia…